Skip to content

OptimizeRx OPRX Interest Paid, Excluding Capitalized Interest, Operating Activity

Interest Paid, Excluding Capitalized Interest, Operating Activity at other companies

Spectral AI, Inc. logo
Spectral AI, Inc.MDAI
Claritev Corporation logo
Claritev CorporationCTEV

Other financials

Income statement

See full
Revenue$19.8M-9.5%
Gross profit$14.9M+11.9%
Operating income$396.0K+119%
Net income-$495.0K+77.5%
EPS (diluted)-$0.03+75.0%

Balance sheet

See full
Cash & equivalents$20.2M+21.7%
Total debt$23.7M-27.7%
Total equity$129.6M+11.5%
Total assets$167.3M-0.3%

Cash flow

See full
Operating cash flow-$467.0K-112%
CapEx$21.0K-22.2%
Free cash flow-$488.0K-113%

Valuation

See full
Market cap$107.34M-54.1%
Enterprise value$110.88M-55.0%
P/E15.7×
P/S-1.2×

Profitability

See full
Gross margin70%+14.1pp
Operating margin13.2%
Net margin6.4%+3.6pp
FCF margin13.4%+4.8pp

Returns & leverage

See full
Return on equity5.6%+3.3pp
Debt / equity0.2×-0.1×
Current ratio5.4×+2.6×

Where this comes from

Reported directly by OptimizeRx in its filing.

Tagged under the XBRL concept us-gaap:InterestPaidNet.

The official record: OptimizeRx’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about OptimizeRx's interest paid, excluding capitalized interest, operating activity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OptimizeRx's interest paid, excluding capitalized interest, operating activity?
OptimizeRx (OPRX) reported interest paid, excluding capitalized interest, operating activity of $798K in Q1 2026.
How has OptimizeRx's interest paid, excluding capitalized interest, operating activity changed year-over-year?
OptimizeRx's interest paid, excluding capitalized interest, operating activity decreased by 28.8% year-over-year, from $1.12M to $798K.
What is the long-term trend for OptimizeRx's interest paid, excluding capitalized interest, operating activity?
Over 2 years (2023 to 2025), OptimizeRx's interest paid, excluding capitalized interest, operating activity has grown at a 85.7% compound annual growth rate (CAGR), from $1.21M to $4.18M.